Little House Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-2,241
Closed -$207K – 137
2021
Q2
$207K Buy
+2,241
New +$191K 0.11% 135

Other funds holding ARKG

Little House Capital's ARKG Position: Q3 2021 in Review

Little House Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 2,241 shares — an estimated $207K sold.

Little House Capital first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $207K in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Little House Capital reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Little House Capital sold 2,241 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $207K.
  • Little House Capital first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
  • Little House Capital's ARK Genomic Revolution ETF position peaked at $207K in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Little House Capital's 13F filing for Q3 2021, filed 15 Nov 2021.